Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q44797474)
Watch
English
Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B.
scientific article published in March 2004
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
title
Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
main subject
tenofovir
1 reference
based on heuristic
inferred from title
author
Alexander Kuo
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Jules Dienstag
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Raymond T Chung
series ordinal
3
object named as
Raymond T Chung
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
language of work or name
English
0 references
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
published in
Clinical Gastroenterology and Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
volume
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
page(s)
266-272
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
cites work
Chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine as initial treatment for chronic hepatitis B in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histological outcome during long-term lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900017-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1542-3565(04)00017-5
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
PubMed ID
15017612
1 reference
stated in
Europe PubMed Central
PubMed ID
15017612
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15017612%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
